theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Neurology

Anemia   

Questions discussed in this category


What are the factors that you would consider for the use of ESA in patients with anemia of CKD with a history of stroke or TIA?
1 Answer available
18153


Papers discussed in this category


Circulation, 2011-12-20
What caused excess strokes in patients randomized to darbepoetin in the trial to reduce cardiovascular events with Aranesp therapy (TREAT)?: no smoking gun.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 2013-01
Dose of erythropoiesis-stimulating agents and adverse outcomes in CKD: a metaregression analysis.

American journal of nephrology, 2013
Cardiovascular toxicity of epoetin-alfa in patients with chronic kidney disease.

Journal of the American Heart Association, 2021 Jun 26
Erythropoietin Use and the Risk of Stroke in Patients on Hemodialysis: A Retrospective Cohort Study in Taiwan.

Related Topics in Neurology

  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Non-malignant Disease
  • Pediatric Hematology/Oncology

Copyright © 2025 theMednet
All Rights Reserved.